Home » Newsletters » BioWorld Science

BioWorld Science

March 7, 2006

View Archived Issues

GlaxoSmithKline sees considerable progress across pipeline

Procyon completes acquisition of Cellpep

Antigenics makes progress on multiple fronts

U.S. clinical data verify safety and efficacy of MAS-063DP for atopic dermatitis

Celgene presents preliminary phase II data on CC-10004 for severe psoriasis

Medinet signs research agreement for activated self gamma-delta T-cell therapy

sanofi-aventis takes over Plavix license in Japan

Novelos raises financing to support pipeline progression

New phase IIa study for IPL-455903 in age-associated memory impairment

Study suggests BioAstin may significantly reduce CRP scores

Design announced for phase III iron therapy program of ferumoxytol

Malignancies reported in phase II HIV study of vicriviroc

Introgen gains confidence for Advexin registration strategy

Phase III study of Fampridine-SR in MS completes enrollment

Living Cell Technologies profiles research developments

AN-2690: preclinical update of topical treatment for onychomycosis

GSK discloses preclinical data on relacatib, a novel cathepsin K inhibitor

Recent patents impart new therapeutic agents for cancer

New compounds with potential use in psychiatric disorders revealed in recent patents

Antibody-cytokine immune complexes could selectively enhance immunotherapy

R-115866 demonstrates efficacy and safety in phase IIa psoriasis trial

Studies assess antibacterial, antiinflammatory activity of AN-0128

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...